28403387|t|Skin Conductance Responses and Neural Activations During Fear Conditioning and Extinction Recall Across Anxiety Disorders
28403387|a|The fear conditioning and extinction neurocircuitry has been extensively studied in healthy and clinical populations, with a particular focus on posttraumatic stress disorder. Despite significant overlap of symptoms between posttraumatic stress disorder and anxiety disorders, the latter has received less attention. Given that dysregulated fear levels characterize anxiety disorders, examining the neural correlates of fear and extinction learning may shed light on the pathogenesis of underlying anxiety disorders. To investigate the psychophysiological and neural correlates of fear conditioning and extinction recall in anxiety disorders and to document how these features differ as a function of multiple diagnoses or anxiety severity. This investigation was a cross-sectional, case-control, functional magnetic resonance imaging study at an academic medical center. Participants were healthy controls and individuals with at least 1 of the following anxiety disorders: generalized anxiety disorder, social anxiety disorder, specific phobia, and panic disorder. The study dates were between March 2013 and May 2015. Two-day fear conditioning and extinction paradigm. Skin conductance responses, blood oxygenation level-dependent responses, trait anxiety scores from the State Trait Anxiety Inventory - Trait Form, and functiona l connectivity. This study included 21 healthy controls (10 women) and 61 individuals with anxiety disorders (36 women). P values reported for the neuroimaging results are all familywise error corrected. Skin conductance responses during extinction recall did not differ between individuals with anxiety disorders and healthy controls (ηp2 = 0.001, P = .79), where ηp2 is partial eta squared. The anxiety group had lower activation of the ventromedial prefrontal cortex (vmPFC) during extinction recall (ηp2 = 0.178, P = .02). A similar hypoactive pattern was found during early conditioning (ηp2 = 0.106, P = .009). The vmPFC hypoactivation was associated with anxiety symptom severity (r = -0.420, P = .01 for conditioning and r = -0.464, P = .004 for extinction recall) and the number of co-occuring anxiety disorders diagnosed (ηp2 = 0.137, P = .009 for conditioning and ηp2 = 0.227, P = .004 for extinction recall). Psychophysiological interaction analyses revealed that the fear network connectivity differed between healthy controls and the anxiety group during fear learning (ηp2 range between 0.088 and 0.176 and P range between 0.02 and 0.003) and extinction recall (ηp2 range between 0.111 and 0.235 and P range between 0.02 and 0.002). Despite no skin conductance response group differences during extinction recall, brain activation patterns between anxious and healthy individuals differed. These findings encourage future studies to examine the conditions longitudinally and in the context of treatment trials to improve and guide therapeutics via advanced neurobiological understanding of each disorder.
28403387	0	16	Skin Conductance	T042	C0814024
28403387	17	26	Responses	T032	C0871261
28403387	31	37	Neural	T169	C3714606
28403387	38	49	Activations	T052	C1879547
28403387	57	61	Fear	T041	C0015726
28403387	62	74	Conditioning	T041	C0009647
28403387	79	89	Extinction	T041	C0015347
28403387	90	96	Recall	T041	C0034770
28403387	104	121	Anxiety Disorders	T048	C0003469
28403387	126	130	fear	T041	C0015726
28403387	131	143	conditioning	T041	C0009647
28403387	148	158	extinction	T041	C0015347
28403387	159	173	neurocircuitry	T062,T170	C0596723
28403387	183	194	extensively	T080	C0205231
28403387	195	202	studied	T062	C2603343
28403387	206	213	healthy	T080	C3898900
28403387	218	226	clinical	T080	C0205210
28403387	227	238	populations	T098	C1257890
28403387	247	263	particular focus	T082	C0205234
28403387	267	296	posttraumatic stress disorder	T048	C0038436
28403387	306	317	significant	T078	C0750502
28403387	318	325	overlap	T079	C1948020
28403387	329	337	symptoms	T184	C1457887
28403387	346	375	posttraumatic stress disorder	T048	C0038436
28403387	380	397	anxiety disorders	T048	C0003469
28403387	414	422	received	T080	C1514756
28403387	423	427	less	T081	C0439092
28403387	428	437	attention	T041	C0004268
28403387	463	467	fear	T041	C0015726
28403387	468	474	levels	T080	C0441889
28403387	475	487	characterize	T052	C1880022
28403387	488	505	anxiety disorders	T048	C0003469
28403387	507	516	examining	T058	C0582103
28403387	521	527	neural	T169	C3714606
28403387	528	538	correlates	T080	C1707520
28403387	542	546	fear	T041	C0015726
28403387	551	561	extinction	T041	C0015347
28403387	562	570	learning	T041	C0023185
28403387	593	605	pathogenesis	T046	C0699748
28403387	620	637	anxiety disorders	T048	C0003469
28403387	642	653	investigate	T169	C1292732
28403387	658	677	psychophysiological	T041	C0018467
28403387	682	688	neural	T169	C3714606
28403387	689	699	correlates	T080	C1707520
28403387	703	707	fear	T041	C0015726
28403387	708	720	conditioning	T041	C0009647
28403387	725	735	extinction	T041	C0015347
28403387	736	742	recall	T041	C0034770
28403387	746	763	anxiety disorders	T048	C0003469
28403387	771	779	document	T170	C1301746
28403387	790	798	features	T080	C2348519
28403387	811	819	function	T169	C0542341
28403387	823	831	multiple	T081	C0439064
28403387	832	841	diagnoses	T033	C0011900
28403387	845	852	anxiety	T033	C0003467
28403387	853	861	severity	T080	C0439793
28403387	868	881	investigation	T058	C0220825
28403387	888	903	cross-sectional	T062	C0010362
28403387	905	917	case-control	T058	C0872128
28403387	919	956	functional magnetic resonance imaging	T060	C0376335
28403387	957	962	study	T062	C2603343
28403387	969	992	academic medical center	T073,T093	C0000872
28403387	994	1006	Participants	T098	C0679646
28403387	1012	1019	healthy	T080	C3898900
28403387	1020	1028	controls	T096	C0009932
28403387	1033	1044	individuals	T098	C0237401
28403387	1068	1077	following	T079	C0332282
28403387	1078	1095	anxiety disorders	T048	C0003469
28403387	1097	1125	generalized anxiety disorder	T048	C0270549
28403387	1127	1150	social anxiety disorder	T048	C4237417
28403387	1152	1167	specific phobia	T048	C0236801
28403387	1173	1187	panic disorder	T048	C0030319
28403387	1193	1198	study	T062	C2603343
28403387	1199	1204	dates	T079	C0011008
28403387	1251	1255	fear	T041	C0015726
28403387	1256	1268	conditioning	T041	C0009647
28403387	1273	1283	extinction	T041	C0015347
28403387	1284	1292	paradigm	T062	C0681797
28403387	1294	1310	Skin conductance	T042	C0814024
28403387	1311	1320	responses	T032	C0871261
28403387	1322	1355	blood oxygenation level-dependent	T042	C1655730
28403387	1356	1365	responses	T032	C0871261
28403387	1367	1372	trait	T032	C0599883
28403387	1373	1387	anxiety scores	T033	C3483978
28403387	1397	1426	State Trait Anxiety Inventory	T060,T170	C0683457
28403387	1429	1434	Trait	T032	C0599883
28403387	1435	1439	Form	T080	C0348078
28403387	1445	1454	functiona	T169	C0542341
28403387	1457	1469	connectivity	T169	C1707489
28403387	1476	1481	study	T062	C2603343
28403387	1482	1490	included	T052	C2700399
28403387	1494	1501	healthy	T080	C3898900
28403387	1502	1510	controls	T096	C0009932
28403387	1515	1520	women	T098	C0043210
28403387	1529	1540	individuals	T098	C0237401
28403387	1546	1563	anxiety disorders	T048	C0003469
28403387	1568	1573	women	T098	C0043210
28403387	1576	1584	P values	T081	C1709380
28403387	1585	1593	reported	T058	C0700287
28403387	1602	1614	neuroimaging	T060	C0679575
28403387	1615	1622	results	T034	C0456984
28403387	1631	1641	familywise	T099	C0015576
28403387	1642	1647	error	T080	C0743559
28403387	1648	1657	corrected	T080	C0205202
28403387	1659	1675	Skin conductance	T042	C0814024
28403387	1676	1685	responses	T032	C0871261
28403387	1693	1703	extinction	T041	C0015347
28403387	1704	1710	recall	T041	C0034770
28403387	1734	1745	individuals	T098	C0237401
28403387	1751	1768	anxiety disorders	T048	C0003469
28403387	1773	1780	healthy	T080	C3898900
28403387	1781	1789	controls	T096	C0009932
28403387	1791	1794	ηp2	T081	C0392762
28403387	1820	1823	ηp2	T081	C0392762
28403387	1827	1846	partial eta squared	T081	C0392762
28403387	1852	1859	anxiety	T033	C0003467
28403387	1860	1865	group	T098	C1257890
28403387	1870	1875	lower	T080	C0205251
28403387	1876	1886	activation	T052	C1879547
28403387	1894	1924	ventromedial prefrontal cortex	T023	C3850122
28403387	1926	1931	vmPFC	T023	C3850122
28403387	1940	1950	extinction	T041	C0015347
28403387	1951	1957	recall	T041	C0034770
28403387	1959	1962	ηp2	T081	C0392762
28403387	1992	2002	hypoactive	T033	C0086439
28403387	2003	2010	pattern	T082	C0449774
28403387	2028	2033	early	T079	C1279919
28403387	2034	2046	conditioning	T041	C0009647
28403387	2048	2051	ηp2	T081	C0392762
28403387	2076	2081	vmPFC	T023	C3850122
28403387	2082	2096	hypoactivation	T052	C1879547
28403387	2101	2116	associated with	T080	C0332281
28403387	2117	2132	anxiety symptom	T033	C0860603
28403387	2133	2141	severity	T080	C0439793
28403387	2167	2179	conditioning	T041	C0009647
28403387	2209	2219	extinction	T041	C0015347
28403387	2220	2226	recall	T041	C0034770
28403387	2236	2242	number	T081	C0237753
28403387	2246	2257	co-occuring	T052	C1709305
28403387	2258	2275	anxiety disorders	T048	C0003469
28403387	2276	2285	diagnosed	T033	C0011900
28403387	2287	2290	ηp2	T081	C0392762
28403387	2313	2325	conditioning	T041	C0009647
28403387	2330	2333	ηp2	T081	C0392762
28403387	2356	2366	extinction	T041	C0015347
28403387	2367	2373	recall	T041	C0034770
28403387	2376	2395	Psychophysiological	T041	C0018467
28403387	2396	2416	interaction analyses	T081	C0237688
28403387	2417	2425	revealed	T080	C0443289
28403387	2435	2439	fear	T041	C0015726
28403387	2440	2460	network connectivity	T040	C0598941
28403387	2478	2485	healthy	T080	C3898900
28403387	2486	2494	controls	T096	C0009932
28403387	2503	2510	anxiety	T033	C0003467
28403387	2511	2516	group	T098	C1257890
28403387	2524	2528	fear	T041	C0015726
28403387	2529	2537	learning	T041	C0023185
28403387	2539	2542	ηp2	T081	C0392762
28403387	2543	2548	range	T081	C1514721
28403387	2577	2578	P	T081	C1709380
28403387	2579	2584	range	T081	C1514721
28403387	2613	2623	extinction	T041	C0015347
28403387	2624	2630	recall	T041	C0034770
28403387	2632	2635	ηp2	T081	C0392762
28403387	2636	2641	range	T081	C1514721
28403387	2670	2671	P	T081	C1709380
28403387	2672	2677	range	T081	C1514721
28403387	2714	2730	skin conductance	T042	C0814024
28403387	2731	2739	response	T032	C0871261
28403387	2740	2745	group	T098	C1257890
28403387	2746	2757	differences	T081	C1705241
28403387	2765	2775	extinction	T041	C0015347
28403387	2776	2782	recall	T041	C0034770
28403387	2784	2789	brain	T023	C0006104
28403387	2790	2800	activation	T052	C1879547
28403387	2801	2809	patterns	T082	C0449774
28403387	2818	2825	anxious	T048	C0849801
28403387	2830	2837	healthy	T080	C3898900
28403387	2838	2849	individuals	T098	C0237401
28403387	2866	2874	findings	T033	C0243095
28403387	2885	2891	future	T079	C0016884
28403387	2892	2899	studies	T062	C2603343
28403387	2903	2910	examine	T058	C0582103
28403387	2915	2925	conditions	T080	C0348080
28403387	2926	2940	longitudinally	T062	C0023981
28403387	2952	2959	context	T078	C0449255
28403387	2963	2979	treatment trials	T062	C0008976
28403387	2983	2990	improve	T033	C0184511
28403387	2995	3013	guide therapeutics	T061	C1562629
28403387	3018	3026	advanced	T080	C0205179
28403387	3027	3042	neurobiological	T091	C0027817
28403387	3043	3056	understanding	T041	C0162340
28403387	3065	3073	disorder	T047	C0012634